Registration is Closing for the 10th Annual Biomarkers Congress 2015 - Europe’s Leading Biomarkers Congress

Oxford Global are proud to be hosting the 10^th Annual Biomarkers Congress, taking place on the 23^rd and 24^th February 2015. Known for its iconic location the congress will be held at the Manchester Central Convention Complex in Manchester UK.

 

Why this Congress?

 

Biomarkers have been at the forefront of the pharmaceutical industry for a number of years; the research and interest into the industry is constantly growing.

 

This Congress brings together over 250 industry leaders, experts and solution providers to discuss the latest advances in biomarker technologies. Furthermore the congress showcases over 55 presentations, case studies and panel discussions featured in 6 interactive streams across the two day congress:

      ·  Biomarkers in Discovery and Development

      ·  Developing Companion Diagnostics

      ·  Biomarker Discovery, Verification & Validation

      ·  Innovations In Biomarker Research

      ·  Biomarkers in Clinical Development & Diagnostics

      ·  Clinical Trials & Personalised Medicine

 

Poster Presentation Award

Join us in Manchester this February to celebrate the 10^th anniversary of this prestigious event. To celebrate the success of this event Oxford Global will be hosting a champagne toast after the first day of the congress. During this a poster award will be presented to the winner of our Poster Presentation Competition. To be in with a chance to win £3,000 you must be a registered delegate with a poster presentation. The competition will be judge by four of our esteemed congress speakers:

 

      ·  Elena S Izmailova, Sr. Director, Global Translational Medicine, Takeda Pharmaceuticals International, Inc.

      ·  Liz Harrington, Director, Translational Science, AstraZeneca

      ·  Dirk Cerneus, Director Science, Clinical Pharmacology, Astellas Pharma

      ·  Jill Richardson, Director, External Alliances, Neurosciences Therapeutic Area and EFPIA coordinator of the IMI PharmaCog project

      ·  Paul Germann, Head Preclinical Safety Germany, Abbvie

 

To find out more please click here

 

We are proud to announce the following speakers and their presentations:

 

Biomarker Discovery And Translational Research By Multi-Omics, Yoshiya Oda, Unit President of Biomarkers & Personalized Medicine Core Function Unit, Eisai Inc.

 

Molecular Imaging Based Companion Diagnostics: A New Paradigm In Drug Development, Susanta Sarkar, Director, Translational/Clinical Imaging, Translational and Experimental Medicine, Sanofi Oncology

 

Identification Of Blood-circulating microRNAs With Clinical Utility For The Management Of Bone Disease, Matthias Hackl, Chief Operating Officer, TAmiRNA GmbH

 

The Scientific, Technical And Cultural Challenges Of Creating A Value For Biomarkers In Clinical Development, Peter Groenen, Head of Translational Science, Actelion Pharmaceuticals Ltd.

 

Prediction And Faster Assessment Of Functional Properties Of New Drug Candidates For Alzheimer’s Disease In Early Clinical Development: The IMI PharmaCog Project, Jill Richardson, Director, External Alliances, Neurosciences Therapeutic Area and EFPIA coordinator of the IMI PharmaCog project,

 

Please click here to download the agenda today!

 

10^th Annual Biomarkers Congress Registration is Closing Soon:

With very limited spaces left to attend, don’t miss out on registering your interest now to secure access to the 10^th Annual Biomarkers Congress.

 

Contact Danielle Dalby today on +44(0) 1865 248455 or e-mail d.dalby@oxfordglobal.co.uk to receive further information on how to book a delegate place.